- Intraperitoneal lymphokine-activated killer cell/interleukin-2 therapy in patients with intra-abdominal cancer: immunologic considerations. Urba, W.J., Clark, J.W., Steis, R.G., Bookman, M.A., Smith, J.W., Beckner, S., Maluish, A.E., Rossio, J.L., Rager, H., Ortaldo, J.R. J. Natl. Cancer Inst. (1989)